1. Amgen. 2015. NEUPOGEN® (filgrastim) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1991. Available from: https://www.pi.amgen.com/∼/media/amgen/repositorysites/pi-amgen-com/neupogen/neupogen_pi_hcp_english.pdf
2. Carnell LS, Blattnig S, Hu S, Huff J, Kim MH, Norman R, Patel Z, Simonsen L, Wu H. 2015. Evidence report: risk of acute radiation syndromes due to solar particle events. NASA Technical Report. JSC-CN-35747.
3. Carnell LS. 2019. Medical Countermeasures: A Strategic Approach for Galactic Cosmic Radiation. NASA Technical Report. Hampton (VA): NASA Langley Research Center.
4. Center for Disease Control and Prevention (CDC). 2019. Acute radiation syndrome: a fact sheet for clinicians. [accessed 2019 May 29]. https://www.cdc.gov/nceh/radiation/emergencies/arsphysicianfactsheet.htm.
5. Incidence of clinical symptoms during long-duration orbital spaceflight